Petauri, a leading purpose-built pharmaceutical services platform, announced the launch of its new channel strategy offering. This expanded service will be part of the organization’s consulting arm, Petauri Advisors, which focuses on pricing, reimbursement, access, and value demonstration.
The Channel Strategy team will collaborate with emerging pharmaceutical manufacturers to define the optimal distribution path and flow for specific drugs, ensuring they reach patients and prescribers effectively. Additionally, this team will support established pharmaceutical companies by assessing their current network performance, developing new strategies for expanded therapeutic areas, and assisting with acquisitions and the integration of new networks.
Health Technology Insights: FAIR Health Launches Alzheimer Decision-Making Tool & Resources
To lead this team, Petauri has hired Kim Cline, an industry veteran with over 15 years of experience supporting commercialization strategy in nuanced drug launches. Cline’s expertise in supporting life sciences start-ups with their drug distribution strategies, combined with her proven industry leadership, positions this team as a strong addition to Petauri’s existing services. Adding this highly specialized area of focus allows the organization to deliver end-to-end solutions that address the full spectrum of challenges faced by pharmaceutical companies. “I am excited to build out this capability of the organization and look forward to bringing fresh ideas, flexible support, and a collaborative model to help pharma teams achieve success with their launches,” said Cline.
Health Technology Insights: AmeriPro Health Acquires Priority Medical Transport and Expands Midwest Presence
“Our channel strategy practice is a natural extension for Petauri Advisors,” said Steve O’Malley, President of Petauri Advisors. “We can better assist our clients with strategy and execution in their payer, pricing, and channel decisions. We are very fortunate to have Kim join our team. Her industry and consulting experience will help propel us forward.”
Health Technology Insights: Germitec Secures $30M to Expand in U.S. & Advance UV-C Disinfection
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
